TozinameranInterstitial pneumonitis: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1903卷 / 1期

关键词：

D O I：

10.1007/s40278-022-13913-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：351 / 351

相关论文

共 50 条

[21] IdelalisibPneumocystis jirovecii pneumonia, pneumonia and pneumonitis: 3 case reports
Reactions Weekly, 2022, 1924 (1) : 246 - 246
[22] BleomycinFatal pneumonitis, pulmonary oedema and sepsis: 3 case reports
Reactions Weekly, 2015, 1571 (1) : 36 - 36
[23] Nivolumab/sintilimabImmunotherapy-induced pneumonitis: 3 case reports
Reactions Weekly, 2023, 1982 (1) : 327 - 327
[24] Ipilimumab/nivolumab/pembrolizumabNeuromuscular disorders/pneumonitis: 3 case reports
Reactions Weekly, 2021, 1851 (1) : 195 - 195
[25] Gimeracil/oteracil/tegafurInfections, pneumonitis and thrombocytopenia: 3 case reports
Reactions Weekly, 2020, 1830 (1) : 169 - 169
[26] VemurafenibRadiation recall dermatitis and radiation pneumonitis: 3 case reports
Reactions Weekly, 2015, 1550 (1) : 204 - 204
[27] CrizotinibVisual toxicity, pneumonitis and liver toxicity: 3 case reports
Reactions Weekly, 2015, 1537 (1) : 95 - 95
[28] Antineoplastics/nivolumab/pembrolizumabNeutropenia, pericarditis and pneumonitis: 3 case reports
Reactions Weekly, 2017, 1665 (1) : 37 - 37
[29] CetuximabDrug induced pneumonitis and hypersensitivity reaction: 3 case reports
Reactions Weekly, 2016, 1583 (1) : 271 - 271
[30] Multiple drugsPseudoprogression of thoracic tumours and pneumonitis: 3 case reports
Reactions Weekly, 2023, 1985 (1) : 364 - 364

← 1 2 3 4 5 →